Sort
16,300 grants matching “fatty liver disease”
Role of alcohol adapted Kupffer cells in the progression and resolution of ALD
$602,586Steven A Weinman · University Of Kansas Medical Center · R01 · FY2024 · AA
Role of alcohol adapted Kupffer cells in the progression and resolution of ALD
$602,586Steven A Weinman · University Of Kansas Medical Center · R01 · FY2025 · AA
Preconceptual Bisphenol and Phthalate Effects on Early Embryonic Development
$602,338Leonardo Trasande · New York University School Of Medicine · R01 · FY2018 · ES
Maternal Obesity and Pediatric NAFLD: Fetal Origins and Long-term outcomes in Non Human Primates
$602,100Jacob E Friedman · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · DK
HDAC1 as a nutrient sensor in the development and progression of NAFLD
$601,906Hang Shi · Georgia State University · R01 · FY2022 · DK
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations
$601,819Veronica Wendy Setiawan · University Of Southern California · R01 · FY2018 · CA
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colon Cancer
$601,386Justin C Brown · Lsu Pennington Biomedical Research Ctr · R01 · FY2023 · CA
Alcohol and gut-brain axis and the role of butyrate on neuroinflammation and pain sensitivity
$601,129Gail Ann Cresci · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AA
Nonalcoholic Steatohepatitis Clinical Research Network
$600,900Arun J Sanyal · Virginia Commonwealth University · U01 · FY2010 · DK
Mapping Diabetes Susceptibility by Expression Traits in African Americans
$600,858Swapan Kumar Das · Wake Forest University Health Sciences · R01 · FY2015 · DK
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH
$600,735Tatiana Kisseleva · University Of California, San Diego · R01 · FY2024 · DK
Project 1 - Determining the contributions of the gut microbiota to the physiologi
$600,732Jeffrey Ivan Gordon · Washington University · P01 · FY2015 · DK
Role of alcohol adapted Kupffer cells in the progression and resolution of ALD
$600,610Steven A Weinman · University Of Kansas Medical Center · R01 · FY2023 · AA
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans
$600,349Daniel Thomas Claiborne · Wistar Institute · R01 · FY2023 · DK
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans
$600,349Daniel Thomas Claiborne · Wistar Institute · R01 · FY2022 · DK
The mTOR-ETV5 signaling in gastric X/A like cells and its role in hepatic lipid metabolism and steatosis
$600,297Weizhen Zhang · University Of Michigan At Ann Arbor · R01 · FY2022 · DK
The mTOR-ETV5 signaling in gastric X/A like cells and its role in hepatic lipid metabolism and steatosis
$600,297Weizhen Zhang · University Of Michigan At Ann Arbor · R01 · FY2023 · DK
The mTOR-ETV5 signaling in gastric X/A like cells and its role in hepatic lipid metabolism and steatosis
$600,297Weizhen Zhang · University Of Michigan At Ann Arbor · R01 · FY2021 · DK
Mechanisms of Alcoholic Liver Disease
$600,071Bin Gao · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$599,884Patrice Mimche · University Of Utah · R01 · FY2021 · DK
Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver
$599,835Qing Miao · New York University D/B/A Nyu Long Island School Of Medicine · R01 · FY2024 · DK
Hepatotoxic Exposures, Progressive Fatty Liver Disease (NASH), and Liver Cancer Risk in the World Trade Center Health Program General Responder Cohort
$599,769Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2018 · OH
Hepatotoxic Exposures, Progressive Fatty Liver Disease (NASH), and Liver Cancer Risk in the World Trade Center Health Program General Responder Cohort
$599,769Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · OH
Hepatotoxic Exposures, Progressive Fatty Liver Disease (NASH), and Liver Cancer Risk in the World Trade Center Health Program General Responder Cohort
$599,769Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2017 · OH
Hepatotoxic Exposures, Progressive Fatty Liver Disease (NASH), and Liver Cancer Risk in the World Trade Center Health Program General Responder Cohort
$599,768Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · OH